StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Just Insane Price

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jun 16, 2021 4:49am

108 Views

Post# 33393985

RE:Just Insane Price

"Liked2Think" is a soft basher, but he lies as blatantly as the hard bashers. So, when he says, "they will not verify that they are currently completing aristotle tests"...
*eyeroll
Tripp said in a public interview that they are completing Aristotle tests... And Liked2Drink knows it, because he's here reading the boards every day.
So, when he plays the hapless ingenue, don't believe a word of it.
He's trying to undermine your confidence in this company. If you fall for it, you'll lose your shares, and if you don't keep your shares, ...
How are you going to enjoy the easy double from here?
Hold your shares and kick these lying bashers to the curb.
GLTA longs!

Liked2Think wrote: being able to buy at 53 and 52 cents. 6.5 cents equivalent to pre reverse split.

Its either a heck of a good buy or Im throwing money away. They are set to make at least 2 million next financials yet this is where we are.

does anyone have total house positions? Volume has been pretty sad so the shorters still seem to have control of the stock even though GAP girl appears to be gone or maybe i just have all of their accounts on ignore and cant tell.

Why are there no insider buying? would they not do that because of the impending AGM? I didnt think they were on a blackout period but with AGM coming up maybe none of the execs would risk that looking fishy.

Looking to be a painful few more months until we get to Q2 results. Hope they are doing at least a few Aristotle tests now but as typical we have no clue if they are or not. After a decade in production they bumble the release which fine they screwed up. They know they screwed that up but virtually no mention of it since. 2.5 months after the release of the product and nothing to add or say how things have gone at all. Are they under a gag order because of the Care deal? The same thing goes for the covid testing though. Never gave out quantities or anything just that they can do 1000 tests a day but appear to only ever do 500 a day. Even when emailing the company they will not verify they are currently completing aristotle tests. Why cant they say that at least? Even without the Care deal completed they should still be doing tests. Did they really say aristotle is released without any possible way to legally complete a test anywhere?